Literature DB >> 34453695

Induced Neural Cells from Human Dental Pulp Ameliorate Functional Recovery in a Murine Model of Cerebral Infarction.

Hideaki Matsumura1,2,3, Aiki Marushima4,5, Hiroshi Ishikawa1,3, Junko Toyomura1,3, Akihiro Ohyama1,3, Miho Watanabe1,3,6, Shohei Takaoka2,3,7, Hiroki Bukawa7, Akira Matsumura1, Yuji Matsumaru1,3, Eiichi Ishikawa1.   

Abstract

Human mesenchymal stem cells are a promising cell source for the treatment of stroke. Their primary mechanism of action occurs via neuroprotective effects by trophic factors, anti-inflammatory effects, and immunomodulation. However, the regeneration of damaged neuronal networks by cell transplantation remains challenging. We hypothesized that cells induced to neural lineages would fit the niche, replace the lesion, and be more effective in improving symptoms compared with stem cells themselves. We investigated the characteristics of induced neural cells from human dental pulp tissue and compared the transplantation effects between these induced neural cells and uninduced dental pulp stem cells. Induced neural cells or dental pulp stem cells were intracerebrally transplanted 5 days after cerebral infarction induced by permanent middle cerebral artery occlusion in immunodeficient mice. Effects on functional recovery were also assessed through behavior testing. We used immunohistochemistry and neuron tracing to analyze the differentiation, axonal extension, and connectivity of transplanted cells to the host's neural circuit. Transplantation of induced neural cells from human dental pulp ameliorated functional recovery after cerebral infarction compared with dental pulp stem cells. The induced neural cells comprised both neurons and glia and expressed functional voltage, and they were more related to neurogenesis in terms of transcriptomics. Induced neural cells had a higher viability than did dental pulp stem cells in hypoxic culture. We showed that induced neural cells from dental pulp tissue offer a novel therapeutic approach for recovery after cerebral infarction.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Cell therapy; Cerebral infarction; Dental pulp; Regenerative therapy; Stem cells; Stroke

Mesh:

Year:  2021        PMID: 34453695     DOI: 10.1007/s12015-021-10223-w

Source DB:  PubMed          Journal:  Stem Cell Rev Rep        ISSN: 2629-3277            Impact factor:   5.739


  38 in total

1.  Cell therapy for ischemic stroke: Are differences in preclinical and clinical study design responsible for the translational loss of efficacy?

Authors:  Li-Li Cui; Dominika Golubczyk; Anna-Maija Tolppanen; Johannes Boltze; Jukka Jolkkonen
Journal:  Ann Neurol       Date:  2019-05-08       Impact factor: 10.422

2.  Human neural stem cells in patients with chronic ischaemic stroke (PISCES): a phase 1, first-in-man study.

Authors:  Dheeraj Kalladka; John Sinden; Kenneth Pollock; Caroline Haig; John McLean; Wilma Smith; Alex McConnachie; Celestine Santosh; Philip M Bath; Laurence Dunn; Keith W Muir
Journal:  Lancet       Date:  2016-08-03       Impact factor: 79.321

3.  Heart Disease and Stroke Statistics-2020 Update: A Report From the American Heart Association.

Authors:  Salim S Virani; Alvaro Alonso; Emelia J Benjamin; Marcio S Bittencourt; Clifton W Callaway; April P Carson; Alanna M Chamberlain; Alexander R Chang; Susan Cheng; Francesca N Delling; Luc Djousse; Mitchell S V Elkind; Jane F Ferguson; Myriam Fornage; Sadiya S Khan; Brett M Kissela; Kristen L Knutson; Tak W Kwan; Daniel T Lackland; Tené T Lewis; Judith H Lichtman; Chris T Longenecker; Matthew Shane Loop; Pamela L Lutsey; Seth S Martin; Kunihiro Matsushita; Andrew E Moran; Michael E Mussolino; Amanda Marma Perak; Wayne D Rosamond; Gregory A Roth; Uchechukwu K A Sampson; Gary M Satou; Emily B Schroeder; Svati H Shah; Christina M Shay; Nicole L Spartano; Andrew Stokes; David L Tirschwell; Lisa B VanWagner; Connie W Tsao
Journal:  Circulation       Date:  2020-01-29       Impact factor: 29.690

4.  Safety and efficacy of multipotent adult progenitor cells in acute ischaemic stroke (MASTERS): a randomised, double-blind, placebo-controlled, phase 2 trial.

Authors:  David C Hess; Lawrence R Wechsler; Wayne M Clark; Sean I Savitz; Gary A Ford; David Chiu; Dileep R Yavagal; Ken Uchino; David S Liebeskind; Alexander P Auchus; Souvik Sen; Cathy A Sila; Jeffrey D Vest; Robert W Mays
Journal:  Lancet Neurol       Date:  2017-03-17       Impact factor: 44.182

5.  Human-induced pluripotent stem cells form functional neurons and improve recovery after grafting in stroke-damaged brain.

Authors:  Koichi Oki; Jemal Tatarishvili; James Wood; Philipp Koch; Somsak Wattananit; Yutaka Mine; Emanuela Monni; Daniel Tornero; Henrik Ahlenius; Julia Ladewig; Oliver Brüstle; Olle Lindvall; Zaal Kokaia
Journal:  Stem Cells       Date:  2012-06       Impact factor: 6.277

6.  Human iPS cell-derived dopaminergic neurons function in a primate Parkinson's disease model.

Authors:  Tetsuhiro Kikuchi; Asuka Morizane; Daisuke Doi; Hiroaki Magotani; Hirotaka Onoe; Takuya Hayashi; Hiroshi Mizuma; Sayuki Takara; Ryosuke Takahashi; Haruhisa Inoue; Satoshi Morita; Michio Yamamoto; Keisuke Okita; Masato Nakagawa; Malin Parmar; Jun Takahashi
Journal:  Nature       Date:  2017-08-30       Impact factor: 49.962

7.  Clinical Outcomes of Transplanted Modified Bone Marrow-Derived Mesenchymal Stem Cells in Stroke: A Phase 1/2a Study.

Authors:  Gary K Steinberg; Douglas Kondziolka; Lawrence R Wechsler; L Dade Lunsford; Maria L Coburn; Julia B Billigen; Anthony S Kim; Jeremiah N Johnson; Damien Bates; Bill King; Casey Case; Michael McGrogan; Ernest W Yankee; Neil E Schwartz
Journal:  Stroke       Date:  2016-06-02       Impact factor: 7.914

Review 8.  The neural crest.

Authors:  Roberto Mayor; Eric Theveneau
Journal:  Development       Date:  2013-06       Impact factor: 6.868

Review 9.  Neuronal replacement therapy: previous achievements and challenges ahead.

Authors:  Sofia Grade; Magdalena Götz
Journal:  NPJ Regen Med       Date:  2017-10-23
View more
  1 in total

Review 1.  Dental-Pulp Stem Cells as a Therapeutic Strategy for Ischemic Stroke.

Authors:  Chikako Nito; Satoshi Suda; Yuko Nitahara-Kasahara; Takashi Okada; Kazumi Kimura
Journal:  Biomedicines       Date:  2022-03-22
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.